Introduction
The global Cardiopulmonary Exercise Testing Market is expected to grow at a CAGR of 4.6 % during the forecast period from 2022 to 2029. Cardiopulmonary exercise testing (CPET) is a diagnostic tool that assesses how well the heart and lungs work together during physical activity. The test helps in detecting cardiovascular and pulmonary diseases, and in monitoring the progress of patients with these conditions. The growth of the market is driven by factors such as the rising prevalence of cardiovascular and pulmonary diseases and the increasing number of awareness programs for early diagnosis and treatment of these diseases. However, the high cost associated with CPET procedures is restraining the growth of the market. The report segments the global cardiopulmonary exercise testing market on the basis of product, application, end-user, and geography. On the basis of product, the market is segmented into stress test systems, portable CPET devices, consumables, and software & services. On the basis of application, the market is segmented into diagnostics, disease management, fitness & wellness, and research applications. On the basis of end-user, the market is segmented into hospitals & clinics and academic & research institutes.
CPET is considered as one of the most important tests in cardiology and pulmonary medicine for risk stratification, diagnosis, prognosis, and therapeutic decision-making. It has emerged as a powerful tool in clinical decision-making due to its prognostic value and ability to guide therapeutic decisions. The rising prevalence of cardiovascular diseases globally is the major factor driving the growth of the CPET market. According to WHO, an estimated 17.9 million people died from cardiovascular diseases in 2016, which accounted for 31% of all global deaths. Moreover, the growing geriatric population is another factor fuelling the growth of this market as they are more prone to chronic diseases such as heart failure and COPD.
Market Drivers
The cardiopulmonary exercise testing market is driven by numerous factors. These drivers include the increasing prevalence of cardiovascular diseases, the growing geriatric population, the rising awareness of fitness and preventative care, and the availability of advanced exercise testing equipment.
The prevalence of cardiovascular diseases is a major driver of the cardiopulmonary exercise testing market. Cardiovascular disease is the leading cause of death globally, accounting for 17.3 million deaths per year. The World Health Organization predicts that this number will rise to 23.6 million by 2030. As the prevalence of cardiovascular diseases increases, so does the need for effective diagnostic and treatment options. Cardiopulmonary exercise testing is an important tool in diagnosing and managing cardiovascular disease.
The growing geriatric population is another key driver of the cardiopulmonary exercise testing market. The aging population is more susceptible to chronic diseases such as heart disease, stroke, and diabetes. This increase in chronic disease incidence is expected to drive demand for cardiopulmonary exercise testing services.
The rising awareness of fitness and preventative care is also driving the market growth. An increasingly health-conscious population is seeking ways to improve their overall fitness and reduce their risk of developing chronic diseases. Cardiopulmonary exercise testing can help individuals assess their fitness level and identify areas for improvement.
Finally, the availability of advanced exercise testing equipment is also contributing to market growth. Newer generations of cardiopulmonary exercise testing systems are more user-friendly.
Report Includes
An overview of the global Cardiopulmonary Exercise Testing market, and related technologies and developments. Analyses of global market trends, with historical data from 2018, 2019, and 2020 estimates and projections of CAGRs through 2029. It also includes breakdowns of the overall Cardiopulmonary Exercise Testing market along with various segments, and by geographic region. Analysis of the stakeholder value chain in the Cardiopulmonary Exercise Testing market and comprehensive profiles of leading companies in the industry
Report Scope
The report forecasts the size of the Cardiopulmonary Exercise Testing market for components from 2020 through 2027
The Executive Summary provides a snapshot of key findings of the report. The introduction chapter includes research scope, market segmentation, research methodology, and definitions and assumptions. It involves extreme rigorous scientific methods, tools and techniques to estimate the market size. Exhaustive secondary research is being carried out to collect information related to the market, the parent market, and the peer market. Primary research is undertaken to validate the assumptions, findings, and sizing with the industry experts professionals across the value chain of the market. Both top-down and bottom-up approaches are employed to estimate the complete market size.
The chapter on market dynamics includes market drivers, restraints, and opportunities which helps familiarise with market potential and upcoming opportunities. The chapter on key insights includes emerging trends from major countries, latest technological advancement, regulatory landscape, SWOT analysis, and porters five forces analysis. This chapter provides detailed insights into the market, which derives the market trends, changing phase of investments, scope of profit potential, and helps to take appropriate business decisions. The chapter on competitive analysis includes profiling of leading companies in the global market to map the leading companies and their focus of interest in the market.
After deriving the market size from the market size estimation process, the total market has been split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and sub-segments, the data triangulation and market breakdown procedures is being used. The data triangulation is carried out by studying various factors and trends from demand and supply perspectives.
Segmentation Analysis:
The Cardiopulmonary Exercise Testing market is segmented on the basis of types, applications , and Region.
Global Cardiopulmonary Exercise Testing market Competitive Analysis:
Key players in the Global Cardiopulmonary Exercise Testing market are Cardinal Health, COSMED SRL, GE Healthcare, Halma PLC, Hill-Rom Holdings, Inc., Koninklijke Philips NV, MGC Diagnostics Corporation, NIHON KOHDEN CORPORATION, Schiller AG, Masimo Corporation, and Vyaire Medical, Inc among other players.
*All our reports are customizable as per customer requirements
This study forecasts revenue and volume growth at global, regional, and country levels from 2018 to 2029. Global Cardiopulmonary Exercise Testing market is distributed on the basis of below mentioned segments:
Global Cardiopulmonary Exercise Testing market, By types:
The global Cardiopulmonary Exercise Testing Market is expected to grow at a CAGR of 4.6 % during the forecast period from 2022 to 2029. Cardiopulmonary exercise testing (CPET) is a diagnostic tool that assesses how well the heart and lungs work together during physical activity. The test helps in detecting cardiovascular and pulmonary diseases, and in monitoring the progress of patients with these conditions. The growth of the market is driven by factors such as the rising prevalence of cardiovascular and pulmonary diseases and the increasing number of awareness programs for early diagnosis and treatment of these diseases. However, the high cost associated with CPET procedures is restraining the growth of the market. The report segments the global cardiopulmonary exercise testing market on the basis of product, application, end-user, and geography. On the basis of product, the market is segmented into stress test systems, portable CPET devices, consumables, and software & services. On the basis of application, the market is segmented into diagnostics, disease management, fitness & wellness, and research applications. On the basis of end-user, the market is segmented into hospitals & clinics and academic & research institutes.
CPET is considered as one of the most important tests in cardiology and pulmonary medicine for risk stratification, diagnosis, prognosis, and therapeutic decision-making. It has emerged as a powerful tool in clinical decision-making due to its prognostic value and ability to guide therapeutic decisions. The rising prevalence of cardiovascular diseases globally is the major factor driving the growth of the CPET market. According to WHO, an estimated 17.9 million people died from cardiovascular diseases in 2016, which accounted for 31% of all global deaths. Moreover, the growing geriatric population is another factor fuelling the growth of this market as they are more prone to chronic diseases such as heart failure and COPD.
Market Drivers
The cardiopulmonary exercise testing market is driven by numerous factors. These drivers include the increasing prevalence of cardiovascular diseases, the growing geriatric population, the rising awareness of fitness and preventative care, and the availability of advanced exercise testing equipment.
The prevalence of cardiovascular diseases is a major driver of the cardiopulmonary exercise testing market. Cardiovascular disease is the leading cause of death globally, accounting for 17.3 million deaths per year. The World Health Organization predicts that this number will rise to 23.6 million by 2030. As the prevalence of cardiovascular diseases increases, so does the need for effective diagnostic and treatment options. Cardiopulmonary exercise testing is an important tool in diagnosing and managing cardiovascular disease.
The growing geriatric population is another key driver of the cardiopulmonary exercise testing market. The aging population is more susceptible to chronic diseases such as heart disease, stroke, and diabetes. This increase in chronic disease incidence is expected to drive demand for cardiopulmonary exercise testing services.
The rising awareness of fitness and preventative care is also driving the market growth. An increasingly health-conscious population is seeking ways to improve their overall fitness and reduce their risk of developing chronic diseases. Cardiopulmonary exercise testing can help individuals assess their fitness level and identify areas for improvement.
Finally, the availability of advanced exercise testing equipment is also contributing to market growth. Newer generations of cardiopulmonary exercise testing systems are more user-friendly.
Report Includes
An overview of the global Cardiopulmonary Exercise Testing market, and related technologies and developments. Analyses of global market trends, with historical data from 2018, 2019, and 2020 estimates and projections of CAGRs through 2029. It also includes breakdowns of the overall Cardiopulmonary Exercise Testing market along with various segments, and by geographic region. Analysis of the stakeholder value chain in the Cardiopulmonary Exercise Testing market and comprehensive profiles of leading companies in the industry
Report Scope
The report forecasts the size of the Cardiopulmonary Exercise Testing market for components from 2020 through 2027
The Executive Summary provides a snapshot of key findings of the report. The introduction chapter includes research scope, market segmentation, research methodology, and definitions and assumptions. It involves extreme rigorous scientific methods, tools and techniques to estimate the market size. Exhaustive secondary research is being carried out to collect information related to the market, the parent market, and the peer market. Primary research is undertaken to validate the assumptions, findings, and sizing with the industry experts professionals across the value chain of the market. Both top-down and bottom-up approaches are employed to estimate the complete market size.
The chapter on market dynamics includes market drivers, restraints, and opportunities which helps familiarise with market potential and upcoming opportunities. The chapter on key insights includes emerging trends from major countries, latest technological advancement, regulatory landscape, SWOT analysis, and porters five forces analysis. This chapter provides detailed insights into the market, which derives the market trends, changing phase of investments, scope of profit potential, and helps to take appropriate business decisions. The chapter on competitive analysis includes profiling of leading companies in the global market to map the leading companies and their focus of interest in the market.
After deriving the market size from the market size estimation process, the total market has been split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and sub-segments, the data triangulation and market breakdown procedures is being used. The data triangulation is carried out by studying various factors and trends from demand and supply perspectives.
Segmentation Analysis:
The Cardiopulmonary Exercise Testing market is segmented on the basis of types, applications , and Region.
Global Cardiopulmonary Exercise Testing market Competitive Analysis:
Key players in the Global Cardiopulmonary Exercise Testing market are Cardinal Health, COSMED SRL, GE Healthcare, Halma PLC, Hill-Rom Holdings, Inc., Koninklijke Philips NV, MGC Diagnostics Corporation, NIHON KOHDEN CORPORATION, Schiller AG, Masimo Corporation, and Vyaire Medical, Inc among other players.
*All our reports are customizable as per customer requirements
This study forecasts revenue and volume growth at global, regional, and country levels from 2018 to 2029. Global Cardiopulmonary Exercise Testing market is distributed on the basis of below mentioned segments:
Global Cardiopulmonary Exercise Testing market, By types:
- Echocardiogram
- Pulse Oximeters
- Stress Blood Pressure Monitors
- Others
- Hospital/Clinical Laboratories
- Diagnostic Centers
- Ambulatory Centers
- Others
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
Cardiopulmonary Exercise Testing MARKET STUDY GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2020-2027
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Cardiopulmonary Exercise Testing Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Segment 1
- 5.2.1. Sub-Segment 1
- 5.2.2. Sub-Segment 2
- 5.3. Market Analysis, Insights and Forecast – By Segment 2
- 5.3.1. Sub-Segment 1
- 5.3.2. Sub-Segment 2
- 5.3.3. Sub-Segment 3
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast – By Segment 3
- 5.4.1. Sub-Segment 1
- 5.4.2. Sub-Segment 2
- 5.4.3. Sub-Segment 3
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Latin America
- 5.5.3. Europe
- 5.5.4. Asia Pacific
- 5.5.5. Middle East and Africa
6. North America Cardiopulmonary Exercise Testing Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Segment 1
- 6.2.1. Sub-Segment 1
- 6.2.2. Sub-Segment 2
- 6.3. Market Analysis, Insights and Forecast – By Segment 2
- 6.3.1. Sub-Segment 1
- 6.3.2. Sub-Segment 2
- 6.3.3. Sub-Segment 3
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast – By Segment 3
- 6.4.1. Sub-Segment 1
- 6.4.2. Sub-Segment 2
- 6.4.3. Sub-Segment 3
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Latin America Cardiopulmonary Exercise Testing Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Segment 1
- 7.2.1. Sub-Segment 1
- 7.2.2. Sub-Segment 2
- 7.3. Market Analysis, Insights and Forecast – By Segment 2
- 7.3.1. Sub-Segment 1
- 7.3.2. Sub-Segment 2
- 7.3.3. Sub-Segment 3
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast – By Segment 3
- 7.4.1. Sub-Segment 1
- 7.4.2. Sub-Segment 2
- 7.4.3. Sub-Segment 3
- 7.4.4. Others
- 7.5. Insights and Forecast – By Country
- 7.5.1. Brazil
- 7.5.2. Mexico
- 7.5.3. Rest of Latin America
8. Europe Cardiopulmonary Exercise Testing Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Segment 1
- 8.2.1. Sub-Segment 1
- 8.2.2. Sub-Segment 2
- 8.3. Market Analysis, Insights and Forecast – By Segment 2
- 8.3.1. Sub-Segment 1
- 8.3.2. Sub-Segment 2
- 8.3.3. Sub-Segment 3
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast – By Segment 3
- 8.4.1. Sub-Segment 1
- 8.4.2. Sub-Segment 2
- 8.4.3. Sub-Segment 3
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. UK
- 8.5.2. Germany
- 8.5.3. France
- 8.5.4. Italy
- 8.5.5. Spain
- 8.5.6. Russia
- 8.5.7. Rest of Europe
9. Asia Pacific Cardiopulmonary Exercise Testing Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Segment 1
- 9.2.1. Sub-Segment 1
- 9.2.2. Sub-Segment 2
- 9.3. Market Analysis, Insights and Forecast – By Segment 2
- 9.3.1. Sub-Segment 1
- 9.3.2. Sub-Segment 2
- 9.3.3. Sub-Segment 3
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast – By Segment 3
- 9.4.1. Sub-Segment 1
- 9.4.2. Sub-Segment 2
- 9.4.3. Sub-Segment 3
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. China
- 9.5.2. India
- 9.5.3. Japan
- 9.5.4. Australia
- 9.5.5. South East Asia
- 9.5.6. Rest of Asia Pacific
10. Middle East & Africa Cardiopulmonary Exercise Testing Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Segment 1
- 10.2.1. Sub-Segment 1
- 10.2.2. Sub-Segment 2
- 10.3. Market Analysis, Insights and Forecast – By Segment 2
- 10.3.1. Sub-Segment 1
- 10.3.2. Sub-Segment 2
- 10.3.3. Sub-Segment 3
- 10.3.4. Others
- 10.4. Market Analysis, Insights and Forecast – By Segment 3
- 10.4.1. Sub-Segment 1
- 10.4.2. Sub-Segment 2
- 10.4.3. Sub-Segment 3
- 10.4.4. Others
- 10.5. Market Analysis, Insights and Forecast – By Country
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Company Market Share Analysis, 2018
- 11.2. Key Industry Developments
- 11.3. Company Profile
- 11.3.1. Company 1
- 11.3.1.1. Business Overview
- 11.3.1.2. Segment 1 & Service Offering
- 11.3.1.3. Overall Revenue
- 11.3.1.4. Geographic Presence
- 11.3.1.5. Recent Development
- 11.3.2. Company 2
- 11.3.3. Company 3
- 11.3.4. Company 4
- 11.3.5. Company 5
- 11.3.6. Company 6
- 11.3.7. Company 7
- 11.3.8. Company 8
- 11.3.9. Company 9
- 11.3.10. Company 10
- 11.3.11. Company 11
- 11.3.12. Company 12
- 11.3.1. Company 1
Research Process
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
